| 1 |
Nemmour A, Stadler TM, Maurer A, Kovacs Z, Serrallach B, Born D, Nemes CM, Broglie MA, Pazahr S, Rupp NJ, Hüllner MW, Stoeckli SJ, Morand GB. Prediction of extranodal extension in oropharyngeal cancer patients and carcinoma of unknown primary: value of metabolic tumor imaging with hybrid PET compared with MRI and CT. Eur Arch Otorhinolaryngol 2023;280:1973-81. [PMID: 36471046 DOI: 10.1007/s00405-022-07765-1] [Reference Citation Analysis]
|
| 2 |
Xu H, Li Y, Zhao W, Quellec G, Lu L, Hatt M. Joint nnU-Net and Radiomics Approaches for Segmentation and Prognosis of Head and Neck Cancers with PET/CT Images. Lecture Notes in Computer Science 2023. [DOI: 10.1007/978-3-031-27420-6_16] [Reference Citation Analysis]
|
| 3 |
Dmytriw AA, Ortega C, Anconina R, Metser U, Liu ZA, Liu Z, Li X, Sananmuang T, Yu E, Joshi S, Waldron J, Huang SH, Bratman S, Hope A, Veit-haibach P. Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up. Cancers 2022;14:3105. [DOI: 10.3390/cancers14133105] [Reference Citation Analysis]
|
| 4 |
Lekanne Dit Deprez LW, Morand GB, Thüring C, Pazahr S, Hüllner MW, Broglie MA. SUVmax for predicting regional control in oropharyngeal cancer. Eur Arch Otorhinolaryngol 2021. [PMID: 34779928 DOI: 10.1007/s00405-021-07169-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Creff G, Devillers A, Depeursinge A, Palard-Novello X, Acosta O, Jegoux F, Castelli J. Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer: A Systematic Review. JAMA Otolaryngol Head Neck Surg 2020;146:471-9. [PMID: 32215611 DOI: 10.1001/jamaoto.2020.0014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 6 |
Bozzetti F, Stanga Z. Does nutrition for cancer patients feed the tumour? A clinical perspective. Critical Reviews in Oncology/Hematology 2020;153:103061. [DOI: 10.1016/j.critrevonc.2020.103061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 7 |
Ibrahim SA, Ahmed ANA, Elsersy HA, Darahem IMH. Elective neck dissection in T1/T2 oral squamous cell carcinoma with N0 neck: essential or not? A systematic review and meta-analysis. Eur Arch Otorhinolaryngol 2020;277:1741-52. [PMID: 32100133 DOI: 10.1007/s00405-020-05866-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 8 |
Schmalfuss IM. Positron Emission Tomography in Head and Neck Cancer. Medical Radiology 2020. [DOI: 10.1007/174_2020_233] [Reference Citation Analysis]
|
| 9 |
Bhatia KSS, King AD. Neck Nodal Disease. Medical Radiology 2020. [DOI: 10.1007/174_2020_238] [Reference Citation Analysis]
|
| 10 |
Tanaka H. Diagnostic Imaging of Metastatic Nodal Disease. Diagnostic Imaging in Head and Neck Cancer 2020. [DOI: 10.1007/978-981-15-3188-0_6] [Reference Citation Analysis]
|
| 11 |
Sekine T. PET in the Diagnosis of Head and Neck Cancer. Diagnostic Imaging in Head and Neck Cancer 2020. [DOI: 10.1007/978-981-15-3188-0_10] [Reference Citation Analysis]
|
| 12 |
Meyer HJ, Gundermann P, Surov A. Associations between FDG-PET and Ki 67-index in head and neck cancer: A meta-analysis. Medicine (Baltimore) 2019;98:e17472. [PMID: 31577779 DOI: 10.1097/MD.0000000000017472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 13 |
Werner J, Hüllner MW, Rupp NJ, Huber AM, Broglie MA, Huber GF, Morand GB. Predictive Value of Pretherapeutic Maximum Standardized Uptake Value (Suvmax) In Laryngeal and Hypopharyngeal Cancer. Sci Rep 2019;9:8972. [PMID: 31222167 DOI: 10.1038/s41598-019-45462-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 14 |
Pedraza S, Ruiz-alonso A, Hernández-martínez AC, Cabello E, Lora D, Pérez-regadera JF. 18F-FDG PET/CT in staging and delineation of radiotherapy volume for head and neck cancer. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2019;38:154-9. [DOI: 10.1016/j.remnie.2018.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 15 |
Mayo Z, Seyedin SN, Mallak N, Mott SL, Menda Y, Graham M, Anderson C. Clinical Utility of Pretreatment and 3-Month 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Standardized Uptake Value in Predicting and Assessing Recurrence in T3-T4 Laryngeal Carcinoma Treated With Definitive Radiation. Ann Otol Rhinol Laryngol 2019;128:595-600. [PMID: 30808209 DOI: 10.1177/0003489419834312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 16 |
Pedraza S, Ruiz-Alonso A, Hernández-Martínez AC, Cabello E, Lora D, Pérez-Regadera JF. 18F-FDG PET/CT in staging and delineation of radiotherapy volume for head and neck cancer. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2019;38:154-9. [PMID: 30655026 DOI: 10.1016/j.remn.2018.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 17 |
Theurer JA. Human Papillomavirus-Related Head and Neck Cancer. Clinical Care and Rehabilitation in Head and Neck Cancer 2019. [DOI: 10.1007/978-3-030-04702-3_4] [Reference Citation Analysis]
|
| 18 |
Massey C, Dharmarajan A, Bannuru RR, Rebeiz E. Management of N0 neck in early oral squamous cell carcinoma: A systematic review and meta-analysis: Oral SCC N0 Neck Elective Neck Dissection. The Laryngoscope 2019;129:E284-98. [DOI: 10.1002/lary.27627] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 19 |
Kann BH, Aneja S, Loganadane GV, Kelly JR, Smith SM, Decker RH, Yu JB, Park HS, Yarbrough WG, Malhotra A, Burtness BA, Husain ZA. Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural Networks. Sci Rep 2018;8:14036. [PMID: 30232350 DOI: 10.1038/s41598-018-32441-y] [Cited by in Crossref: 92] [Cited by in F6Publishing: 96] [Article Influence: 18.4] [Reference Citation Analysis]
|
| 20 |
Kılıç S, Kılıç SS, Shah KP, Eloy JA, Baredes S, Mahmoud OM, Park RCW. Predictors of Clinicopathologic Stage Discrepancy in Oropharyngeal Squamous Cell Carcinoma: A National Cancer Database Study. Otolaryngol Head Neck Surg 2018;158:309-18. [PMID: 29039250 DOI: 10.1177/0194599817736501] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Zhong L, Li C, Ren Y, Wu D. Prognostic value of 18F-fluorodeoxyglucose PET parameters and inflammation in patients with nasopharyngeal carcinoma. Oncol Lett 2017;14:5004-12. [PMID: 29085513 DOI: 10.3892/ol.2017.6816] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 22 |
Yap WK, Chang YC, Tseng CK, Hsieh CH, Chao YK, Su PJ, Hou MM, Yang CK, Pai PC, Lin CR, Hsieh CE, Wu YY, Hung TM. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer. Dis Esophagus 2017;30:1-10. [PMID: 28575243 DOI: 10.1093/dote/dox021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 23 |
Kale H, Rath TJ. Chapter 3 The Role of PET/CT in Squamous Cell Carcinoma of the Head and Neck. Semin Ultrasound CT MR 2017;38:479-94. [PMID: 29031365 DOI: 10.1053/j.sult.2017.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 24 |
Folkert MR, Setton J, Apte AP, Grkovski M, Young RJ, Schöder H, Thorstad WL, Lee NY, Deasy JO, Oh JH. Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics. Phys Med Biol 2017;62:5327-43. [PMID: 28604368 DOI: 10.1088/1361-6560/aa73cc] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 25 |
Cacicedo J, Fernandez I, Del Hoyo O, Navarro A, Gomez-Iturriaga A, Pijoan JI, Martinez-Indart L, Escudero J, Gomez-Suarez J, de Zarate RO, Perez JF, Bilbao P, Rades D. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma. Clin Transl Oncol 2017;19:1337-49. [PMID: 28540535 DOI: 10.1007/s12094-017-1674-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 26 |
Rath TJ, Narayanan S, Hughes MA, Ferris RL, Chiosea SI, Branstetter BF 4th. Solid Lymph Nodes as an Imaging Biomarker for Risk Stratification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma. AJNR Am J Neuroradiol 2017;38:1405-10. [PMID: 28450437 DOI: 10.3174/ajnr.A5177] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 27 |
Chan SC, Cheng NM, Hsieh CH, Ng SH, Lin CY, Yen TC, Hsu CL, Wan HM, Liao CT, Chang KP, Wang JJ. Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. Oncotarget 2017;8:62606-21. [PMID: 28977973 DOI: 10.18632/oncotarget.15904] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 28 |
Lombardi M, Cascone T, Guenzi E, Stecco A, Buemi F, Krengli M, Carriero A. Predictive value of pre-treatment apparent diffusion coefficient (ADC) in radio-chemiotherapy treated head and neck squamous cell carcinoma. Radiol Med 2017;122:345-52. [PMID: 28188603 DOI: 10.1007/s11547-017-0733-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 29 |
Li H, Becker N, Raman S, Chan TC, Bissonnette JP. The value of nodal information in predicting lung cancer relapse using 4DPET/4DCT. Med Phys 2015;42:4727-33. [PMID: 26233200 DOI: 10.1118/1.4926755] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 30 |
Gyawali B, Shimokata T, Honda K, Ando Y. Chemotherapy in locally advanced head and neck squamous cell carcinoma. Cancer Treatment Reviews 2016;44:10-6. [DOI: 10.1016/j.ctrv.2016.01.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 31 |
Ng SH, Liao CT, Lin CY, Chan SC, Lin YC, Yen TC, Chang JT, Ko SF, Fan KH, Wang HM. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and (18)F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation. Eur Radiol. 2016;26:4162-4172. [PMID: 26911889 DOI: 10.1007/s00330-016-4276-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 32 |
Manca G, Vanzi E, Rubello D, Giammarile F, Grassetto G, Wong KK, Perkins AC, Colletti PM, Volterrani D. 18F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications. Eur J Nucl Med Mol Imaging 2016;43:1360-75. [DOI: 10.1007/s00259-015-3294-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 33 |
Oruc Z, Buyukbayram ME, Kaplan MA, Urakcı Z, Küçüköner M, Isıkdogan A. Association between standardized uptake value and survival in patients with locally advanced or metastatic squamous cell head and neck cancer. Journal of Oncological Science 2016;1:1-4. [DOI: 10.1016/j.jons.2015.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 34 |
de Bree R, Ljumanovic R, Hazewinkel MJ, Witte BI, Castelijns JA. Radiologic extranodal spread and matted nodes: Important predictive factors for development of distant metastases in patients with high-risk head and neck cancer: Radiologic extranodal spread and matted nodes as predictors for distant metastases. Head Neck 2016;38:E1452-8. [DOI: 10.1002/hed.24257] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 35 |
Kitajima K, Suenaga Y, Sugimura K. Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma. Jpn J Radiol 2015;33:776-89. [DOI: 10.1007/s11604-015-0495-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 36 |
Raylman RR, Stolin AV, Sompalli P, Randall NB, Martone PF, Clinthorne NH. Investigation of a Dedicated, High Resolution PET/CT Scanner for Staging and Treatment Planning of Head and Neck Cancer. IEEE Trans Nucl Sci 2015;62:2057-2066. [DOI: 10.1109/tns.2015.2463727] [Reference Citation Analysis]
|
| 37 |
García Vicente A, Soriano Castrejón Á, Andrés Jiménez Londoño G. PET/CT in radiotherapy planning in head and neck cancers. Médecine Nucléaire 2015;39:465-470. [DOI: 10.1016/j.mednuc.2015.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 38 |
Sharma G. Diagnostic aids in detection of oral cancer: An update. World J Stomatol 2015; 4(3): 115-120 [DOI: 10.5321/wjs.v4.i3.115] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 39 |
Klement RJ, Champ CE. Calories, carbohydrates, and cancer therapy with radiation: exploiting the five R's through dietary manipulation. Cancer Metastasis Rev 2014;33:217-29. [PMID: 24436017 DOI: 10.1007/s10555-014-9495-3] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 40 |
Meeuwis J, Hoekstra OS, Witte BI, Boellaard R, Leemans CR, de Bree R. 18FDG SUV in the primary tumor and lymph node metastases is not predictive for development of distant metastases in high risk head and neck cancer patients. Oral Oncol 2015;51:536-40. [PMID: 25735655 DOI: 10.1016/j.oraloncology.2015.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 41 |
Peters TT, Senft A, Hoekstra OS, Castelijns J, Witte BI, Leemans CR, de Bree R. Pretreatment screening on distant metastases and head and neck cancer patients: Validation of risk factors and influence on survival. Oral Oncology 2015;51:267-71. [DOI: 10.1016/j.oraloncology.2014.12.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 42 |
Ng SH, Lin CY, Chan SC, Lin YC, Yen TC, Liao CT, Chang JT, Ko SF, Wang HM, Chang CJ, Wang JJ. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation. PLoS One 2014;9:e115933. [PMID: 25531391 DOI: 10.1371/journal.pone.0115933] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 43 |
Georges P, Rajagopalan K, Leon C, Singh P, Ahmad N, Nader K, Kubicek GJ. Chemotherapy advances in locally advanced head and neck cancer. World J Clin Oncol 2014; 5(5): 966-972 [PMID: 25493232 DOI: 10.5306/wjco.v5.i5.966] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 44 |
Alluri KC, Tahari AK, Wahl RL, Koch W, Chung CH, Subramaniam RM. Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma. AJR Am J Roentgenol 2014;203:897-903. [PMID: 25247958 DOI: 10.2214/AJR.14.12497] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 45 |
Klement RJ. Restricting carbohydrates to fight head and neck cancer-is this realistic? Cancer Biol Med 2014;11:145-61. [PMID: 25364576 DOI: 10.7497/j.issn.2095-3941.2014.03.001] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
|
| 46 |
Paidpally V, Chirindel A, Chung CH, Richmon J, Koch W, Quon H, Subramaniam RM. FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma. AJR Am J Roentgenol 2014;203:W139-45. [PMID: 25055289 DOI: 10.2214/AJR.13.11654] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 47 |
Furukawa M, Dillon JK, Futran ND, Anzai Y. The prevalence of lymph node metastases in clinically N0 necks with oral cavity squamous cell carcinoma: is CT good enough for nodal staging? Acta Radiol 2014;55:570-8. [PMID: 23963150 DOI: 10.1177/0284185113499326] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 48 |
Kitajima K, Suenaga Y, Kanda T, Miyawaki D, Yoshida K, Ejima Y, Sasaki R, Komatsu H, Saito M, Otsuki N, Nibu K, Kiyota N, Minamikawa T, Sugimura K. Prognostic value of FDG PET imaging in patients with laryngeal cancer. PLoS One 2014;9:e96999. [PMID: 24818750 DOI: 10.1371/journal.pone.0096999] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 49 |
Shum JW, Dierks EJ. Evaluation and Staging of the Neck in Patients with Malignant Disease. Oral and Maxillofacial Surgery Clinics of North America 2014;26:209-21. [DOI: 10.1016/j.coms.2014.01.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 50 |
Kuhn FP, Hüllner M, Mader CE, Kastrinidis N, Huber GF, von Schulthess GK, Kollias S, Veit-haibach P. Contrast-Enhanced PET/MR Imaging Versus Contrast-Enhanced PET/CT in Head and Neck Cancer: How Much MR Information Is Needed? J Nucl Med 2014;55:551-8. [DOI: 10.2967/jnumed.113.125443] [Cited by in Crossref: 98] [Cited by in F6Publishing: 104] [Article Influence: 10.9] [Reference Citation Analysis]
|
| 51 |
Castelli J, Simon A, Acosta O, Haigron P, Nassef M, Henry O, Chajon E, de Crevoisier R. The role of imaging in adaptive radiotherapy for head and neck cancer. IRBM 2014;35:33-40. [DOI: 10.1016/j.irbm.2013.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 52 |
Champ CE, Palmer JD, Volek JS, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Shi W. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme. J Neurooncol 2014;117:125-31. [PMID: 24442482 DOI: 10.1007/s11060-014-1362-0] [Cited by in Crossref: 134] [Cited by in F6Publishing: 144] [Article Influence: 14.9] [Reference Citation Analysis]
|
| 53 |
Noguerol TM, Sánchez RS, Barbero JPM, Fernández AR, Luna A. Functional Imaging in Clinical Use for the Assessment of Lymph Nodes in Oncological Patients. Functional Imaging in Oncology 2014. [DOI: 10.1007/978-3-642-40582-2_29] [Reference Citation Analysis]
|
| 54 |
Picchio M, Kirienko M, Mapelli P, Dell'Oca I, Villa E, Gallivanone F, Gianolli L, Messa C, Castiglioni I. Predictive value of pre-therapy (18)F-FDG PET/CT for the outcome of (18)F-FDG PET-guided radiotherapy in patients with head and neck cancer. Eur J Nucl Med Mol Imaging 2014;41:21-31. [PMID: 23990143 DOI: 10.1007/s00259-013-2528-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 55 |
Kaka AS, Kumar B, Kumar P, Wakely PE Jr, Kirsch CM, Old MO, Ozer E, Agrawal A, Carrau RE, Schuller DE, Siddiqui F, Teknos TN. Highly aggressive human papillomavirus-related oropharyngeal cancer: clinical, radiologic, and pathologic characteristics. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;116:327-35. [PMID: 23770280 DOI: 10.1016/j.oooo.2013.04.011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 56 |
Lodder WL, Lange CA, van Velthuysen MF, Hauptmann M, Balm AJ, van den Brekel MW, Pameijer FA. Can extranodal spread in head and neck cancer be detected on MR imaging. Oral Oncology 2013;49:626-33. [DOI: 10.1016/j.oraloncology.2013.02.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 57 |
Farah C, Bhatia N, John K, Lee B. Minimum intervention dentistry in oral medicine. Aust Dent J 2013;58:85-94. [DOI: 10.1111/adj.12054] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 58 |
Teoh M, Beveridge S, Wood K, Whitaker S, Adams E, Rickard D, Jordan T, Nisbet A, Clark CH. Volumetric-modulated arc therapy (RapidArc) vs. conventional fixed-field intensity-modulated radiotherapy for 18F-FDG-PET-guided dose escalation in oropharyngeal cancer: A planning study. Medical Dosimetry 2013;38:18-24. [DOI: 10.1016/j.meddos.2012.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 59 |
Schoenfeld JD, Kovalchuk N, Subramaniam RM, Truong MT. PET/CT of cancer patients: part 2, deformable registration imaging before and after chemotherapy for radiation treatment planning in head and neck cancer. AJR Am J Roentgenol 2012;199:968-74. [PMID: 23096167 DOI: 10.2214/AJR.12.8562] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 60 |
Balgude A, Bryson TC, Mukherji SK. Neck Masses and Adenopathy: Evidence-Based Neuroimaging. Evidence-Based Neuroimaging Diagnosis and Treatment 2013. [DOI: 10.1007/978-1-4614-3320-0_38] [Reference Citation Analysis]
|
| 61 |
Krause BJ, Schwarzenböck S, Souvatzoglou M. FDG PET and PET/CT. Recent Results Cancer Res 2013;187:351-69. [PMID: 23179888 DOI: 10.1007/978-3-642-10853-2_12] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 62 |
Furukawa M, Anzai Y. Diagnosis of Cervical Lymph Node Metastasis in Head and Neck Cancer: Evidence-Based Neuroimaging. Evidence-Based Neuroimaging Diagnosis and Treatment 2013. [DOI: 10.1007/978-1-4614-3320-0_41] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 63 |
Paidpally V, Chirindel A, Lam S, Agrawal N, Quon H, Subramaniam RM. FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma. Imaging Med. 2012;4:633-647. [PMID: 23482696 DOI: 10.2217/iim.12.60] [Cited by in Crossref: 85] [Cited by in F6Publishing: 89] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 64 |
Garsa AA, Chang AJ, Dewees T, Spencer CR, Adkins DR, Dehdashti F, Gay HA, Thorstad WL. Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma. J Radiat Oncol 2013;2:27-34. [PMID: 24563726 DOI: 10.1007/s13566-012-0065-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 65 |
Siddiqui F, Faulhaber PF, Yao M, Le QT. The Application of FDG-PET as Prognostic Indicators in Head and Neck Squamous Cell Carcinoma. PET Clin 2012;7:381-94. [PMID: 27157645 DOI: 10.1016/j.cpet.2012.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 66 |
Zhao K, Luo XM, Zhou SH, Liu JH, Yan SX, Lu ZJ, Yang SY, Lin LL, Dong MJ. ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor. Cancer Biother Radiopharm 2012;27:685-93. [PMID: 22834634 DOI: 10.1089/cbr.2011.1134] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 67 |
Chauhan A, Kulshrestha P, Kapoor S, Singh H, Jacob MJ, Patel M, Ganguly M. Comparison of PET/CT with conventional imaging modalities (USG, CECT) in evaluation of N0 neck in head and neck squamous cell carcinoma. Med J Armed Forces India 2012;68:322-7. [PMID: 24532898 DOI: 10.1016/j.mjafi.2012.02.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 68 |
Kositwattanarerk A, Oh M, Kudo T, Kiyono Y, Mori T, Kimura Y, Maruyama R, Fujibayashi Y, Fujieda S, Okazawa H. Different distribution of (62) Cu ATSM and (18)F-FDG in head and neck cancers. Clin Nucl Med. 2012;37:252-257. [PMID: 22310251 DOI: 10.1097/rlu.0b013e31823eaadb] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 69 |
Prestwich RJ, Sykes J, Carey B, Sen M, Dyker KE, Scarsbrook AF. Improving target definition for head and neck radiotherapy: a place for magnetic resonance imaging and 18-fluoride fluorodeoxyglucose positron emission tomography? Clin Oncol (R Coll Radiol) 2012;24:577-89. [PMID: 22592142 DOI: 10.1016/j.clon.2012.04.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 70 |
Prestwich RJ, Bhatnagar P, Chowdhury FU, Patel CN, Dyker KE, Coyle C, Sen M, Scarsbrook AF. The Impact of (18)F-FDG PET CT Prior to Chemoradiotherapy for Stage III/IV Head and Neck Squamous Cell Carcinoma. ISRN Oncol 2012;2012:636379. [PMID: 22548190 DOI: 10.5402/2012/636379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 71 |
Mehta V, Ferris RL. Elective neck dissection: the gold standard for oral cavity carcinoma. Oral Oncol 2012;48:291-2. [PMID: 22436886 DOI: 10.1016/j.oraloncology.2012.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 72 |
Moon SH, Choi JY, Lee HJ, Son YI, Baek CH, Ahn YC, Park K, Lee KH, Kim BT. Prognostic value of 18F-FDG PET/CT in patients with squamous cell carcinoma of the tonsil: comparisons of volume-based metabolic parameters. Head Neck. 2013;35:15-22. [PMID: 22307893 DOI: 10.1002/hed.22904] [Cited by in Crossref: 92] [Cited by in F6Publishing: 98] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 73 |
Yao M, Lu M, Savvides PS, Rezaee R, Zender CA, Lavertu P, Buatti JM, Machtay M. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2012;83:684-689. [PMID: 22169673 DOI: 10.1016/j.ijrobp.2011.07.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 74 |
Chan S, Chang JT, Lin C, Ng S, Wang H, Liao C, Chang C, Lin S, Yen T. Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification. Nuclear Medicine Communications 2011;32:989-96. [DOI: 10.1097/mnm.0b013e3283495662] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 75 |
Kubicek GJ, Heron DE. Clinical Applications of PET-Computed Tomography in Planning Radiotherapy: General Principles and an Overview. PET Clinics 2011;6:105-15. [DOI: 10.1016/j.cpet.2011.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 76 |
Bhatia KSS, King AD. Neck Nodal Disease. Medical Radiology 2011. [DOI: 10.1007/174_2011_382] [Reference Citation Analysis]
|
| 77 |
Schmalfuss IM. Positron Emission Tomography in Head and Neck Cancer. Medical Radiology 2011. [DOI: 10.1007/174_2011_384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
